S2652
RTT - Patient experience and quality of life
ESTRO 2026
prior to the planning appointment, with subsequent questionnaires sent 3 days before weekly review and long-term follow-up visits.Patient education was provided at consent (verbal and leaflet), with clinician education delivered through CPD sessions.MyCareaccess andquestionnaire completion rateswere assessed to establish patient compliance and acceptance. Results: Between 21st July and 8th October, 638 questionnaires were distributed to 317 patients (63 PBT; 254 RT). Of these, 257 patients (81%) had an active MyCare account. Adjusting for MyCare access, 120 of 504 questionnaires (23.8%) were completed. A further eleven questionnaires (2.2%) were started but not submitted. Sixty-five patients completed questionnaires at multiple timepoints. Completion rates varied by treatment site: Head and Neck (20.4%), Neuro-oncology (24.3%), Lung (27.1%), and Prostate (29.6%).Baseline completion was lower (15.1%) compared with on-treatment (30.7%) and post- treatment timepoints (20.7%). Conclusion: Initial findings demonstrate the feasibility and early acceptance of automated ePROM integration within RT and PBT practice, particularly during treatment. The adjusted completion rate of 23.8% indicates promising patient engagement during the early implementation phase. Clinician feedback was positive, emphasising the clinical value of ePROM data in supporting consultations.While previous studies have reported completion rates exceeding 45% once ePROM systems are fully embedded into routine workflows, these initial results provide an encouraging foundation for continued optimisation. The data suggests that routine digital symptom monitoring can be integrated into clinical practice with minimal disruption. Future work will focus on increasing patient participation across all timepoints, with an initial target of achieving >30% completion across tumour sites, expanding implementation to additional disease groups, and auditing barriers such as language, health literacy, and digital accessibility to promote equitable engagement. Keywords: PROMs, quality of life, symptom reporting Proffered Paper 1220 Patient perceptions of tattoos in breast radiotherapy: preliminary findings from the BRIGHT study Andrea Lastrucci 1,2 , Nicola Iosca 1,2 , Emanuele Baroni 3 , Livia Marrazzo 4,5 , Costanza Gori 6 , Yannick Wandael 1 , Gabriele Simontacchi 2 , Caterina Primi 6 , Laura Belloni 3 , Renzo Ricci 1 , Cinzia Talamonti 4,5 , Icro Meattini 4,2 , Stefania Pallotta 4,5 , Lorenzo Livi 4,2
marker-less setup. Marker-less techniques combined with 6D couch achieved comparable positioning accuracy to marker-based methods. Maximum mean setup deviations in the longitudinal axis were 3.3 ± 1.3 mm (M), 3.3 ± 1.5 mm (M_6D), 2.8 ± 1.3 mm (ML), and 3.0 ± 1.5 mm (ML_6D). No significant differences were found in setup or IGRT time. Marker-less setups reduced total treatment time by 27.8%. Conclusion: Marker-less setups using SGRT are feasible for breast radiotherapy, providing comparable accuracy and reduced treatment times. Both patients and RTTs preferred this method over traditional marker-based approaches. References: 1. Rigley J, Radiography. 20202. Asada H, Patient Prefer. Adherence. 20223. Yamauchi R, J. Med. Imaging Radiat. Sci. 20244. Darréon J, Cancer Radiother. 20235. Oonsiri P, Radiat. Oncol. J. 20196. Oonsiri P, Rad Onc. 20227. Oonsiri S,Imaging Radiat. Oncol. 20248. Giantsoudi D,Pract. Radiat. Oncol. 20239. Jeong Y,J. Radiat. Res. Appl. Sci. 202510. Sasaki M,Radiol Phys and Technol. 2023 11. Mueller B,Tech Innov Patient Support Radiat Oncol. 202512. Mast ME,Tech Innov Patient Support Radiat Oncol. 2023. 13. Kost S, Pract. Radiat. Oncol. 201914. Svestad JG,Radiother. Oncol. 202215. Kang S, Rad Onc. 2023 16. Lastrucci A, Crit. Rev. Oncol. Hematol. 202417. Al - Hallaq HA, Med. Phys. 2022 Keywords: markerless , surface-guided radiotherapy Digital Poster Highlight 779 Clinical integration of automated ePROMs within radiotherapy and proton beam therapy Danielle Fairweather, Elizabeth Davies, Paula Treasure, Justhna Motlib, Nazima Haji, Laura Allington, Jayna Patel Cancer Division, University College London Hospitals NHS Foundation Trust, London, United Kingdom Purpose/Objective: Routine use of PROMs is recommended by the NHS England RT service specification and the Proton Clinical Outcome Unit (PCOU). National policy supports the implementation of PROMs to improve patient–clinician communication and identify unmet needs. This service evaluation aimed to assess theinitial acceptance ofautomated ePROMswithin a large single-centreRT and PBT service. Material/Methods: Two PROM datasets (including EORTC-QLQ-C30 + site- specific module)were implemented within our Epic electronic health records system anddistributed automatically via the MyCare patient portal. Baseline questionnaires were issued automatically 24 hours
Made with FlippingBook - Share PDF online